Chair(s): Mirjam Stahl, Clemence Martin
Session type: Symposium
James D. Chalmers
Session content
Mirjam Stahl
Replay
Slides
Nicholas Simmonds
Replay
Slides
Stephanie Thee
Replay
Slides
Lessons from Bronchiectasis not caused by CF
James D. Chalmers
Replay
Slides
Discussion and Q&A
Session aims
After this session, the auditorium has gained insights into inflammation in CF lung disease starting soon after birth and the problems with treating this aspect of CF. Furthermore, the role of antimicrobial therapy, especially in the era of highly effective CFTR modulator therapy, will be discussed. In addition, lessons that can be learned from the treatment of the heterogenous group of people with non-CF bronchiectasis will be presented to stimulate transfer of knowledge to CF, where bronchiectasis is as a hallmark of lung disease.